A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

May 29, 2025

Study Completion Date

August 29, 2025

Conditions

Ventricular Tachycardia

Interventions

DRUG

Dantrolene/Ryanodex

muscle relaxant

DRUG

Placebo

Controlled placebo of saline administered Intravenous; 1 mg/kg IV over 3 minutes, one time dose

Trial Locations (1)

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER

NCT04134845 - A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias. | Biotech Hunter | Biotech Hunter